PARTNER 3 Trial - Aortic Valve-in-Valve (NCT03003299)

🧪 Interventions in This Study

• Edwards SAPIEN 3/SAPIEN 3 Ultra THV (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (51 Sites)

Showing the first 25 of 51 sites.

• Banner University Medical Center — Phoenix, Arizona
• University of California Los Angeles — Los Angeles, California
• Sutter Medical Center — Sacramento, California
• Kaiser Permanente San Francisco — San Francisco, California
• Stanford University Medical Center — Stanford, California
• UC Health Northern Colorado/Medical Center of the Rockies — Loveland, Colorado
• Hartford Hospital — Hartford, Connecticut
• JFK Medical Center/ Atlantic Clinical Research Collaborative — Atlantis, Florida
• University of Florida, Gainesville — Gainesville, Florida
• Emory University Hospital — Atlanta, Georgia
• Northwestern University Hospital — Chicago, Illinois
• Rush University Medical Center — Chicago, Illinois
• Northshore University HealthSystem — Evanston, Illinois
• Prairie Education and Research Cooperative — Springfield, Illinois
• Ochsner Clinic Foundation — New Orleans, Louisiana
• Brigham and Women's Hospital — Boston, Massachusetts
• Henry Ford Hospital — Detroit, Michigan
• William Beaumont Hospital — Royal Oak, Michigan
• University of Minnesota Medical Center — Minneapolis, Minnesota
• Mayo Clinic — Rochester, Minnesota
• Saint Luke's Hospital of Kansas City Mid America — Kansas City, Missouri
• Washington University/ Barnes-Jewish Hospital — St Louis, Missouri
• Nebraska Heart Institute — Lincoln, Nebraska
• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
• Newark Beth Israel — Newark, New Jersey

📞 Contact the Study Coordinator

Phone: (949) 250-2500

Email: THV_CT.gov@Edwards.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Aortic Stenosis

• PERIGON Pivotal Trial — Los Angeles, California
• ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement — Birmingham, Alabama
• PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis — Birmingham, Alabama
• Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study — Tucson, Arizona
• Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study) — Edmonton, Alberta
• Systematic Ambulatory ECG Monitoring Following TAVI — Québec, Quebec

Explore by condition: All Aortic Stenosis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.